Igor Tudorache
Overview
Explore the profile of Igor Tudorache including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
156
Citations
2210
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Immohr M, Hettlich V, Kindgen-Milles D, Brandenburger T, Feldt T, Aubin H, et al.
Thorac Cardiovasc Surg
. 2023 May;
72(4):311-319.
PMID: 37146634
Background: Coronavirus disease 2019 (COVID-19)-related acute respiratory distress syndrome requiring veno-venous extracorporeal membrane oxygenation (vv-ECMO) is related with poor outcome, especially in Germany. We aimed to analyze whether changes in...
12.
Sommer W, Franz M, Aburahma K, Saipbaev A, Flothmann K, Yablonski P, et al.
Transpl Int
. 2023 May;
36:11071.
PMID: 37125386
Donor shortages have led transplant centers to extend their criteria for lung donors. Accepting lung donors ≥70 years of age has previously shown good short-term outcomes; however, no mid- and...
13.
Bobylev D, Horke A, Avsar M, Cvitkovic T, Boethig D, Hazekamp M, et al.
Cell Tissue Bank
. 2023 Mar;
25(1):55-66.
PMID: 36917328
For decades, bovine jugular vein conduits (BJV) and classic cryopreserved homografts have been the two most widely used options for pulmonary valve replacement (PVR) in congenital heart disease. More recently,...
14.
Franz M, De Manna N, Schulz S, Ius F, Haverich A, Cebotari S, et al.
Thorac Cardiovasc Surg
. 2023 Mar;
72(8):607-613.
PMID: 36858067
Background: The minimally invasive mitral valve procedure warrants minimal surgical trauma and might influence the postoperative course positively, especially in old patients. In this retrospective study, we reviewed our experience...
15.
Schilling T, Cebotari S, Kaufeld T, Tudorache I, Brandes G, Hartung D, et al.
J Funct Biomater
. 2023 Feb;
14(2).
PMID: 36826872
The surgical reconstruction of dysfunctional myocardium is necessary for patients with severe heart failure. Autologous biomaterials, such as vascularized patch materials, have a regenerative potential due to in vivo remodeling....
16.
Immohr M, Mehdiani A, Oehler D, Hettlich V, Jenkins F, Westenfeld R, et al.
Clin Transplant
. 2023 Feb;
37(5):e14939.
PMID: 36812498
Intro: Recently, the impact of circadian rhythm and daytime variation on surgical outcomes has attracted interest. Although studies for coronary artery and aortic valve surgery report contrary results, effects on...
17.
Franz M, Aburahma K, Avsar M, Boethig D, Greer M, Alhadidi H, et al.
Eur J Cardiothorac Surg
. 2023 Feb;
63(3).
PMID: 36810928
Objectives: Lack of organ donors demands transplantation of older lung allografts for recipients between 0 and 50 years. So far, it has not yet been investigated whether donor-recipient age mismatch...
18.
Sugimura Y, Kalampokas N, Arikan M, Rellecke P, Dalyanoglu H, Tudorache I, et al.
Interdiscip Cardiovasc Thorac Surg
. 2023 Feb;
36(1).
PMID: 36802258
Objectives: Perioperative mortality and complications still remain high after left ventricular assist device (LVAD) implantation, especially in highly compromised patient cohorts. Here, we evaluate the effects of preoperative Levosimendan therapy...
19.
MPembele R, Roth S, Nucaro A, Stroda A, Tenge T, Lurati Buse G, et al.
Eur J Med Res
. 2023 Jan;
28(1):16.
PMID: 36624515
Background: Orthotopic heart transplantation (HTX) is the gold standard to treat end-stage heart failure. Numerous risk stratification tools have been developed in the past years. However, their clinical utility is...
20.
Tenge T, Roth S, MPembele R, Lurati Buse G, Boenner F, Ballazs C, et al.
Life (Basel)
. 2022 Dec;
12(12).
PMID: 36556331
The two main surgical options to treat end-stage heart failure are heart transplantation (HTx) or left ventricular assist device (LVAD) implantation. In hemodynamically stable patients, the decision for HTx listing...